These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 5988706

  • 1. [The combination of corticoids, spironolactone, salidiuretics and mannitol according to a particular schema of treatment of ascitic cirrhosis].
    Colucci CF.
    Schweiz Med Wochenschr; 1966 May 21; 96(20):660-5. PubMed ID: 5988706
    [No Abstract] [Full Text] [Related]

  • 2. [Prolonged treatment of ascitic cirrhosis by the combination of a saldiuretic and a spironolactone].
    Tolot F, Dechavannes M, Fiere D.
    Lyon Med; 1966 Jan 02; 215(1):29-35. PubMed ID: 5904663
    [No Abstract] [Full Text] [Related]

  • 3. [Current treatment of the edematous ascitic syndrome in alcoholic liver cirrhosis].
    Savoye B, Gayet C.
    J Med Lyon; 1969 Dec 20; 50(177):1831-41. PubMed ID: 5374238
    [No Abstract] [Full Text] [Related]

  • 4. Effect of intravenous mannitol in mobilization of resistant cirrhotic ascites.
    Raza MA, Qureshi UF, Humayoun MA, Waseem T, Akram J.
    Eur J Gastroenterol Hepatol; 2011 Feb 20; 23(2):184-8. PubMed ID: 21183857
    [Abstract] [Full Text] [Related]

  • 5. Refractory ascites: can it be defined only by the response to furosemide and spironolactone?
    Kalambokis G, Tsianos EV.
    Liver Int; 2010 Oct 20; 30(9):1394; author reply 1395-6. PubMed ID: 20738777
    [No Abstract] [Full Text] [Related]

  • 6. [Comparative study of diuretic drugs used in cirrhotic and ascitic patients].
    Lennhoff M, Duhalt R, Peña JC.
    Rev Invest Clin; 1968 Oct 20; 20(2):165-80. PubMed ID: 5721631
    [No Abstract] [Full Text] [Related]

  • 7. High doses of spironolactone in the treatment of liver cirrhosis with ascites.
    Papadoyanakis N, Darsinos J, Alexandrou K, Karli J.
    Br J Clin Pract; 1972 Jan 20; 26(1):27-32. PubMed ID: 5025912
    [No Abstract] [Full Text] [Related]

  • 8. [Treatment of cirrhosis with ascites by corticoids].
    Vesin.
    Clinique (Paris); 1965 Oct 31; 60(612):647-8. PubMed ID: 5858996
    [No Abstract] [Full Text] [Related]

  • 9. [THE CURRENT TREATMENT OF CIRRHOTIC ASCITES].
    CONTE M.
    Presse Med (1893); 1964 Jun 13; 72():1725-8. PubMed ID: 14154051
    [No Abstract] [Full Text] [Related]

  • 10. [The action of glucocorticoids and saluretics on the glomerular filtration and plasma volume in ascitic cirrhosis].
    Vesin P, Traverso H, Roberti A.
    Schweiz Med Wochenschr; 1965 Aug 28; 95(35):1157-60. PubMed ID: 5843807
    [No Abstract] [Full Text] [Related]

  • 11. [Influence of diuretics on the survival of 180 patients with cirrhosis of the liver and ascites].
    Robert M, Portmann B.
    Schweiz Med Wochenschr; 1969 Feb 08; 99(6):178-82. PubMed ID: 5781367
    [No Abstract] [Full Text] [Related]

  • 12. [Effects of triamterene in combination with other diuretics in liver cirrhosis].
    Polli E.
    Minerva Med; 1963 Oct 10; 54(81 Suppl):3018-23. PubMed ID: 5877333
    [No Abstract] [Full Text] [Related]

  • 13. [Treatment of cirrhotic edemas with triamterene, amiloride and spirolactone. New clinical and biological facts].
    Vesin P.
    Schweiz Med Wochenschr; 1971 Mar 20; 101(11):398-401. PubMed ID: 5558553
    [No Abstract] [Full Text] [Related]

  • 14. Clinical trial: short-term effects of combination of satavaptan, a selective vasopressin V2 receptor antagonist, and diuretics on ascites in patients with cirrhosis without hyponatraemia--a randomized, double-blind, placebo-controlled study.
    Ginès P, Wong F, Watson H, Terg R, Bruha R, Zarski JP, Dudley F, NormoCAT Study Investigators.
    Aliment Pharmacol Ther; 2010 Apr 20; 31(8):834-45. PubMed ID: 20102356
    [Abstract] [Full Text] [Related]

  • 15. [Clinical and biochemical study of the therapeutic effect of the diuretic triamterene in ascitogenic cirrhosis].
    Păunescu-Podanu A, Demirian H, Ionitã C, Georgescu D, Tarachiu A, Anghel R, Rubingher L.
    Med Interna (Bucur); 1968 May 20; 20(5):523-30. PubMed ID: 5735425
    [No Abstract] [Full Text] [Related]

  • 16. [Diuretic treatment and metabolic alkalosis in ascitic liver cirrhosis].
    Grassi V, Porcellati C, Corea L, Todisco T.
    Minerva Nefrol; 1968 May 20; 15(4):258-60. PubMed ID: 5745815
    [No Abstract] [Full Text] [Related]

  • 17. [Triamterene in the treatment of liver cirrhosis with ascites].
    Rodes J, Bosch J, Arroyo V, Nicolau I, Teres J, Bruguera M.
    Rev Clin Esp; 1972 Dec 31; 127(6):1101-8. PubMed ID: 4663288
    [No Abstract] [Full Text] [Related]

  • 18. Amiloride (MK-870), a new antikaluretic diuretic. Comparison to other antikaluretic diuretics in patients with liver disease and ascites.
    Yamada S, Reynolds TB.
    Gastroenterology; 1970 Dec 31; 59(6):833-41. PubMed ID: 5486268
    [No Abstract] [Full Text] [Related]

  • 19. THE MANAGEMENT OF ASCITES.
    SMITH AN, MCMANUS J.
    Rev Surg; 1964 Dec 31; 21():1-16. PubMed ID: 14106700
    [No Abstract] [Full Text] [Related]

  • 20. [Contribution to the study of the treatment of the ascitic syndrome of cirrhosis by the combination of spironolactone and sulfonamide diuretic. Initial therapy and supportive therapy. Apropos of 55 cases].
    Fraisse H, Perret M, Etaix JP.
    J Med Lyon; 1967 Feb 05; 48(114):173-83. PubMed ID: 5600100
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.